Therapy Areas: Vaccines
Avance Biosciences registers with CLIA program
27 February 2025 - Avance Biosciences, a provider of analytical and bioanalytical services for the pharmaceutical industry, announced on Wednesday that it has registered with the Clinical Laboratory I...
GSK receives approval from US FDA for Penmenvy 5-in-1 meningitis vaccine
17 February 2025 - Biopharmaceutical company GSK plc (LSE/NYSE: GSK) announced on Monday that it has received approval from the US Food and Drug Administration (FDA) for Penmenvy, its 5-in-1 meningoco...
hVIVO secures GBP2m contract for final stage of hMPV characterisation study
17 February 2025 - Contract Research Organisation (CRO) hVIVO plc (AIM: HVO), a global leader in human challenge clinical trials, announced on Monday that it has signed a GBP2m contract with a new bio...
EU approves CSL and Arcturus Therapeutics' self-amplifying mRNA COVID-19 vaccine
14 February 2025 - Australian biotechnology company CSL Limited (ASX:CSL) (USOTC:CSLLY) and US-based mRNA medicines and vaccines company Arcturus Therapeutics (Nasdaq: ARCT) announced on Friday that t...
Sanofi and J&J discontinue phase 3 study of E. coli vaccine candidate
13 February 2025 - Healthcare companies Sanofi S.A. (Euronext Paris:SAN) (Nasdaq:SNY) and Johnson & Johnson (J&J) (NYSE:JNJ) revealed on Thursday that they have discontinued the phase 3 E.mbra...
Bain Capital to acquire Mitsubishi Tanabe Pharma in USD3.3bn deal
7 February 2025 - Alternative investment firm Bain Capital announced on Friday that it has signed a definitive agreement to acquire Mitsubishi Tanabe Pharma Corporation (MTPC) in a carve-out transacti...